BioSpace News Archive

Deals

Elysium Health™ Announces $40 Million Series C Financing Led by GISEV Family Office

Joined by Mayo Clinic Ventures, WTI, General Catalyst, Morningside Ventures, and Breyer Capital

December 23, 2019
·
2 min read
Business

Auburn’s Harrison School of Pharmacy establishes Center for Opioid Research, Education and Outreach

In an effort to combat a public health crisis that affects those in Alabama and throughout the country, Auburn University’s Harrison School of Pharmacy has established the Center for Opioid Research, Education and Outreach, or COACH.

December 23, 2019
·
5 min read
Deals

Liminal BioSciences Comments on Unusual Market Activity

Liminal BioSciences Inc., is issuing this news release in light of unusual trading activity related to the common shares of the Company on the Toronto Stock Exchange and Nasdaq.

December 23, 2019
·
3 min read
Business

NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207

NewLink Genetics Corporation announced that the company has entered into an exclusive worldwide license agreement with Ellipses Pharma Limited for the development of and rights to commercialize NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor camptothecin.

December 23, 2019
·
4 min read
Business

Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region

Emmaus Life Sciences, Inc. reported that it expects to receive shortly the initial purchase orders relating to taiba Healthcare’s early access program for Endari® in certain countries in the Middle East and North Africa region.

December 23, 2019
·
4 min read
Deals

CEL-SCI Announces Proposed Underwritten Public Offering of Common Stock

CEL-SCI Corporation announced that it intends to offer shares of its common stock for sale in an underwritten public offering.

December 23, 2019
·
4 min read
Deals

Exicure Announces the Closing of its Offering of Common Stock

Exicure, Inc. announced the closing of its previously announced underwritten public offering of 10,000,000 shares of its common stock to the public at $2.75 per share.

December 23, 2019
·
4 min read
Deals

Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Axsome Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 2,300,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase additional shares, at the public offering price of $87.00 per share.

December 23, 2019
·
4 min read
BioCapital

Leidos, Intel, and First Genesis Earn ACT-IAC Blockchain Innovations Award

Leidos, Intel Corporation, and First Genesis announced their collaborative approach in developing blockchain technologies to improve healthcare has earned the American Council for Technology and Industry Advisory Council’s 2019 Audience Choice Award.

December 23, 2019
·
4 min read
Biotech Beach

Good Samaritan Hospital Joins PIH Health Network

California Attorney General Approves PIH Health’s Member Substitution of Good Samaritan Hospital, Los Angeles

December 23, 2019
·
4 min read